Gubra
  • Services
    • CRO NASH
    • CRO CKD
    • CRO CVD
    • CRO diabetes
    • CRO obesity
    • CRO Customized services
  • Discovery
    • Target Discovery
    • Drug Discovery
    • StreaMLine
  • Capabilities
    • In vivo pharmacology
    • Histology & Stereology
    • Imaging
    • Sequencing & Bioinformatics
    • Ex vivo assays
    • Molecular pharmacology
    • Peptide chemistry
    • Gubra video gallery
  • Publications
  • Careers
  • About us
    • Company
    • Leadership
    • Events
    • Webinars
    • News
    • Corporate Social Responsibility
    • CSR Activities
Select Page

Chronic efficacy studies

At Gubra, we have developed a diet-induced obesity rat model. One of the hallmarks of our DIO rodent model is our ability to measure food preference changes. Note that liraglutide shifts food preference towards chow.

Read article: Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.

Body weight change
Palatable Gubra Diet
Body composition
Chow diet
  • Company
  • Careers
  • CSR
  • Contact
  • Privacy policy
© 2021 Gubra
We use cookies to ensure that we give you the best experience on our website. Please accept usage of cookies before continuing.AcceptNoRead our policy